Burden of hip fracture using disability-adjusted life-years: a pooled analysis of prospective cohorts in the CHANCES consortium by Papadimitriou, Nikos et al.
www.thelancet.com/public-health   Vol 2   May 2017 e239
Articles
Burden of hip fracture using disability-adjusted life-years: 
a pooled analysis of prospective cohorts in the CHANCES 
consortium
Nikos Papadimitriou*, Konstantinos K Tsilidis*, Philippos Orfanos, Vassiliki Benetou, Evangelia E Ntzani, Isabelle Soerjomataram, 
Annemarie Künn-Nelen, Ulrika Pettersson-Kymmer, Sture Eriksson, Hermann Brenner, Ben Schöttker, Kai-Uwe Saum, Bernd Holleczek, 
Francine D Grodstein, Diane Feskanich, Nicola Orsini, Alicja Wolk, Andrea Bellavia, Tom Wilsgaard, Lone Jørgensen, Paolo Boffetta, 
Dimitrios Trichopoulos†, Antonia Trichopoulou
Summary
Background No studies have estimated disability-adjusted life-years (DALYs) lost due to hip fractures using real-life 
follow-up cohort data. We aimed to quantify the burden of disease due to incident hip fracture using DALYs in 
prospective cohorts in the CHANCES consortium, and to calculate population attributable fractions based on DALYs 
for specific risk factors.
Methods We used data from six cohorts of participants aged 50 years or older at recruitment to calculate DALYs. We 
applied disability weights proposed by the National Osteoporosis Foundation and did a series of sensitivity analyses to 
examine the robustness of DALY estimates. We calculated population attributable fractions for smoking, body-mass 
index (BMI), physical activity, alcohol intake, type 2 diabetes and parity, use of hormone replacement therapy, and oral 
contraceptives in women. We calculated summary risk estimates across cohorts with pooled analysis and random-
effects meta-analysis methods.
Findings 223 880 men and women were followed up for a mean of 13 years (SD 6). 7724 (3·5%) participants developed 
an incident hip fracture, of whom 413 (5·3%) died as a result. 5964 DALYs (27 per 1000 individuals) were lost due to 
hip fractures, 1230 (20·6%) of which were in the group aged 75–79 years. 4150 (69·6%) DALYs were attributed to 
disability. Current smoking was the risk factor responsible for the greatest hip fracture burden (7·5%, 95% CI 
5·2–9·7) followed by physical inactivity (5·5%, 2·1–8·5), history of diabetes (2·8%, 2·1–4·0), and low to average BMI 
(2·0%, 1·4–2·7), whereas low alcohol consumption (0·01–2·5 g per day) and high BMI had a protective effect.
Interpretation Hip fracture can lead to a substantial loss of healthy life-years in elderly people. National public health 
policies should be strengthened to reduce hip fracture incidence and mortality. Primary prevention measures should 
be strengthened to prevent falls, and reduce smoking and a sedentary lifestyle.
Funding European Community’s Seventh Framework Programme.
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Introduction
Mortality has been traditionally the most common indicator 
for evaluation of the burden of disease in a population.1 
However, large increases in life expectancy in the past few 
decades have led to the development of new summary 
measures of population health, such as the disability-
adjusted life-year (DALY), which accounts not only for 
mortality, but also for morbidity and quality of life.2 One 
DALY can be interpreted as a year in a perfect state of health 
lost due to a disease. DALYs were introduced in 1993, and 
have been used since by WHO, the Global Burden of 
Disease (GBD) collaborators, and others to estimate and 
compare the burden of diseases and injuries worldwide.3
Osteoporotic fractures are common in elderly people 
(aged ≥65 years), and are an important cause of mortality 
and morbidity, especially in high-income countries.4 Hip 
fracture is the most serious form of osteoporotic fracture 
because of the resulting high mortality, disability, need 
for long-term institutional care, and associated high 
medical costs.5,6 In 2000, an estimated 1·6 million hip 
fractures occurred worldwide, and this number is 
expected to increase to 6·3 million by 2050.7 Hip 
fractures are more prevalent in northern Europe and the 
USA and less prevalent in Africa and South America, 
with Asian countries lying somewhere between.8 
However, in the past two decades, the incidence seems 
to have stabilised in high-income countries, but 
increased in Asian countries.7 Two studies of aggregated 
modelled national data have estimated the burden of 
disease due to hip fractures using DALYs. One of these 
studies was done in Iran9 and the other was a global 
study showing that an estimated 1·75 million DALYs 
were lost globally in 1990 due to hip fractures, 
representing 0·1% of the total burden of disease.5 
However, no studies have calculated the burden of 
disease using real-life follow-up cohort data. Therefore, 
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we estimated DALYs due to hip fracture in a large cohort 
consortium of middle-aged and elderly Europeans and 
North Americans, and calculated population attributable 
fractions for several risk factors.
Methods
Study design and participants
CHANCES is a consortium of 14 cohorts from Europe 
and the USA that was established in 2010 to produce 
evidence on determinants of healthy ageing in the elderly 
population.10 Data for the present study were provided 
from six cohorts (the Cohort Of Swedish Men [COSM], 
European Prospective Investigation into Cancer and 
Nutrition [EPIC]-Elderly, Epidemiological Study on 
Chances of Prevention, Early Recognition and Optimised 
Treatment of Chronic Diseases in the Older Population 
[ESTHER], Nurses’ Health Study [NHS], Swedish 
Mammography Cohort [SMC], and Tromsø Study) that 
had information about incident hip fractures. We 
included only participants aged 50 years or older at 
recruitment. The appendix p 1 shows detailed information 
about this consortium, its component studies, the 
harmonisation process across the cohorts, and the hip 
fracture assessment methods. All participants provided 
written informed consent and approval for the study was 
obtained from the ethics committees at the participating 
institutions.
Estimation of disability-adjusted life-years
The DALY is a measure of overall disease burden that 
combines years lost due to premature mortality (years of 
lost life [YLL]) and years of healthy life lost due to 
disability (YLD).11 To calculate the YLL, we multiplied the 
number of deaths due to incident hip fracture by the 
expected life-years remaining at the respective age of 
death on the basis of the Coale and Demeny model life 
table, West level 26.3 To calculate the YLD, we multiplied 
the number of incident hip fracture cases by the duration 
of the disease (recorded after fracture) and a disability 
weight, which reflects the severity of the disease, ranging 
from 0 (perfect health) to 1 (death). We also calculated the 
ratio of YLD to YLL to show the relative difference 
between the two quantities. We calculated DALYs overall 
and separately by sex, age group (5 year groups), and 
participating cohort.
Besides the mortality that is directly attributed to a hip 
fracture, the increased all-cause excess mortality in the 
first year after a hip fracture has been suggested to be 
partly attributable to existing comorbidities, and about 
25% of the all-cause mortality can be attributed to the hip 
fracture itself,12 which we used in our calculations. We 
used the disability weights proposed by the National 
Osteoporosis Foundation, assigning a weight of 0·468 
for the first year after the fracture, 0·17 for the second 
year, and discounting the weight by 10% per year for 
subsequent years.13,14
We did sensitivity analyses to examine the effect of the 
aforementioned assumptions in the final results. We 
explored different values for the excess mortality 
attributed to hip fractures (ie, 50%, 100%, and no excess 
mortality),5 and used different disability weights as 
proposed in the initial GBD study,3 the modifications 
proposed by Bertram and colleagues,15 and the disability 
weights proposed in the Netherlands burden of disease 
study.16 The estimation of DALYs traditionally includes 
two social value functions, an age-weighting function, 
and a time discount rate (3%); we did sensitivity analyses 
to assess the effect of omitting these functions.
Research in context
Evidence before the study
We searched PubMed from 1966, to Sept 30, 2016, for 
published articles that investigated the burden of hip fractures 
using disability-adjusted life-years (DALYs), and for articles 
estimating population attributable fractions on the basis of 
DALYs for specific hip fracture risk factors. We identified 
two relevant studies. One of these studies was done in Iran and 
the other was a global study showing that an estimated 
1·75 million DALYs were lost due to hip fractures, representing 
0·1% of the total burden of disease, the largest part of which was 
in high-income countries. However, no publications calculated 
the burden of disease using cohort data or calculated population 
attributable fractions for risk factors causing loss of healthy 
life-years due to hip fracture.
Added value of this study
To our knowledge, this study is the first to estimate DALYs lost 
due to hip fractures using data from prospective cohorts, and 
population attributable fractions for hip fracture risk factors. In 
a large cohort consortium of middle-aged and elderly 
Europeans and North Americans, we used real-life follow-up 
data to prospectively estimate hip fracture incidence, mortality, 
distribution of risk factors and confounding variables. 
5964 DALYs (27 per 1000 individuals) were lost due to hip 
fractures. Disability was the predominant component of DALYs. 
Current smoking was the risk factor responsible for the greatest 
hip fracture burden followed by physical inactivity and history 
of diabetes.
Implications of all the available evidence
Our findings suggest that hip fractures are an important cause 
primarily of disability, but also mortality, among middle-aged and 
older adults. Considerable opportunities exist to ameliorate the 
burden of hip fractures via a focus on treatments that will 
facilitate a rapid and complete recovery. Primary prevention 
measures should be strengthened to prevent falls, and individuals 
should be encouraged to avoid smoking and a sedentary lifestyle.
Articles
www.thelancet.com/public-health   Vol 2   May 2017 e241
Estimation of population attributable fractions
We calculated population attributable fractions with 
the generalised Greenland formula,17 which measured the 
proportion of hip fracture incidence in the population 
that can be attributed to an exposure. We used eight known 
or strongly suspected risk factors of hip fracture, 
including cigarette smoking, alcohol consumption, 
body-mass index (BMI), physical activity, type 2 diabetes 
and parity, use of hormone replacement therapy (HRT), 
and oral contraceptives in women. Information about 
assessment of these risk factors is provided in the 
appendix. Cox proportional hazard models were 
implemented to estimate the hazard ratios (HRs) and the 
95% CIs by cohort for the association between the 
aforementioned risk factors with both the incidence and 
mortality of hip fractures. The HRs for hip fracture 
incidence were used in the calculation of population 
attributable fractions for YLD, whereas the HRs for 
mortality were used in the calculations for YLL. Those 
two quantities were added and then divided by the total 
number of DALYs to obtain the overall population 
attributable fractions. All the statistical models were 
stratified by sex and age at recruitment, and were 
mutually adjusted for the examined risk factors.
The models for the reproductive factors were further 
adjusted for age at first full-term pregnancy, breast-
feeding, and menopausal status, and premenopausal 
women were excluded in the model for HRT. 
Proportionality of hazards was verified by examination of 
the slope of the Schoenfeld residuals. Missing values 
were set into separate categories and missing indicators 
were included in the models.
We calculated summary risk estimates across cohorts 
with pooled analysis and random-effects meta-analysis 
methods. We assessed heterogeneity between studies 
with the Cochran Q test and the I² statistic. All statistical 
analyses were done with Stata (version 11), and the 
population attributable fractions were calculated with the 
punafcc command.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had final responsibility for 
the decision to submit for publication.
Results
After exclusion of 1131 individuals with prevalent hip 
fractures, 223 880 participants from six cohorts were 
followed up for an average of 13 years. Table 1 shows the 
study and participant characteristics at recruitment. 
The mean age at recruitment was more than 60 years for 
all cohorts. The difference between the numbers of women 
(N=170 911) and men (N=52 969) recruited is because 
the large NHS and SMC cohorts recruited only women. 
The proportion of individuals with a BMI of less than 
21·5 kg/m² at recruitment ranged from 4·9% in ESTHER 
to 11·4% in NHS. Regarding lifestyle factors, the proportion 
of current smokers ranged from 12·8% in EPIC-Elderly 
to 31% in Tromsø. About 80% of study participants in 
SMC and COSM exercised vigorously, whereas the 
proportion ranged from 11% to 42% in the remaining 













Recruitment period 1992–99 2000–02 1994–95 1976–77 1987–90 1997
Follow-up time (years) 10·9 (3·8) 11 (2·3) 13·2 (4·4) 13·9 (6·9) 13·6 (NR) 13 (NR)
Age (years) 65·5 (5·0) 62·1 (6·6) 62·9 (9·6) 61 (0·7) 62·6 (9·0) 62·8 (8·5)
Sex
Female 7722 (58·3%) 5420 (55·0%) 5279 (52·7%) 115 713 (100%) 36 777 (100%) 0
Male 5505 (41·6%) 4433 (45·0%) 4735 (47·3%) 0 0 38 296 (100%)
BMI (kg/m²)
<18·5 74 (0·6%) 48 (0·5%) 133 (1·3%) 1200 (1%) NR† NR†
18·5–21·5 592 (4·5%) 432 (4·4%) 846 (8·4%) 11 996 (10·4%) NR NR
21·5–25 2542 (19·2%) 2220 (22·5%) 3146 (31·4%) 31 535 (27·2%) NR NR
25–30 5535 (41·8%) 4632 (47%) 4342 (43·4%) 34 456 (29·8%) NR NR
30–35 3261 (24·7%) 1931 (19·6%) 1251 (12·5%) 15 068 (13%) NR NR
≥35 1158 (8·7%) 574 (5·8%) 266 (2·7%) 7849 (6·8%) NR NR
Unknown 65 (0·5%) 16 (0·2%) 30 (0·3%) 13 609 (11·8%) NR NR
Smoking status
Current 1686 (12·8%) 1631 (16·6%) 3108 (31%) 17 038 (14·7%) 8199 (22·3%) 9148 (23·9%)
Former 2500 (18·9%) 3160 (32%) 3558 (35·5%) 44 700 (38·6%) 8116 (22.1%) 14 941 (39%)
Never 8665 (65·5%) 4793 (48·7%) 3338 (33·4%) 49 696 (43%) 19 663 (53·5%) 13 622 (35·6%)
Unknown 376 (2·8%) 269 (2·7%) 10 (0·1%) 4279 (3·7%) 799 (2·1%) 585 (1·5%)
(Table 1 continues on next page)
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contraceptives ranged from 7·8% in EPIC-Elderly to 
55·1% in ESTHER, and the proportion who used HRT 
ranged from 7·4% in EPIC-Elderly to 59·4% in NHS.
A total of 7724 incident cases of hip fracture and 
413 deaths were identified (table 2). The largest age-
standardised incidence was recorded in the Tromsø 
study, whereas mortality was highest in SMC (table 2). In 
the three cohorts that included both sexes, the incidence 
was roughly two times higher in women than in men.
Amongst the total CHANCES population over the 
13 year follow-up period, the number of DALYs lost was 
5964, of which 70% was attributed to YLD rather than 
YLL (table 3). DALYs were three times higher in women 













(Continued from previous page)
Current alcohol consumption (g per day)
0 3854 (29·1%) 2884 (29·3%) 4856 (48·5%) 34 942 (30·2%) NR NR
0·01–2·5 4249 (32·1%) 965 (9·8%) 1948 (19·5%) 19 896 (17·2%) NR NR
2·5–5 1391 (10·5%) 1278 (13%) 1296 (12·9%) 9301 (8%) NR NR
5–10 1559 (11·8%) 1722 (17·5%) 1120 (11·2%) 9613 (8·3%) NR NR
10–15 574 (4·4%) 907 (9·2%) 424 (4·2%) 8197 (7·1%) NR NR
≥15 1575 (11·9%) 1145 (11·6%) 265 (2·7%) 10 545 (9·1%) NR NR
Unknown 25 (0·2%) 952 (9·6%) 105 (1%) 23 219 (20·1%) NR NR
Vigorous physical activity
Yes 2008 (15·2%) 4136 (42%) 3222 (32·2%) 13 141 (11·4%) 29 901 (81·3%) 31 572 (82·4%)
No 7678 (58%) 5687 (57·7%) 6676 (66·7%) 86 972 (75·2%) 1813 (4·9%) 2373 (6·2%)
Unknown 3541 (26·8%) 30 (0·3%) 116 (1·1%) 15 600 (13·4%) 5063 (13·8%) 4351 (11·4%)
Diabetes
Yes 1521 (11·5%) 1069 (10·8%) 364 (3·6%) 8100 (7%) 1571 (4·3%) 2722 (7·1%)
No 11 636 (88%) 8213 (83·4%) 9611 (96%) 107 613 (93%) 35 206 (95·7%) 35 574 (92·9%)
Unknown 70 (0·5%) 571 (5·8%) 39 (0·4%) 0 0 0
Age at first full-term 
pregnancy (years)
24·5 (4·6) 23·3 (4.1) 32·9 (9.4) 25·2 (3·4) 23·9 (4·7) NA
Ever had a full-term pregnancy
Yes 6523 (84·5%) 4691 (86·6%) 4086 (77·4%) 106 309 (91·9%) 32 730 (89%) NA
No 608 (7·9%) 729 (13·4%) 383 (7·3%) 6865 (5·9%) 4047 (11%) NA
Unknown 591 (7·6%) 0 (0%) 810 (15·3%) 2539 (2·2%) 0 NA
Ever breastfed‡
Yes 4911 (75·3%) 3091 (65·9%) 3587 (87·8%) 58 238 (54·8%) NR NA
No 423 (6·5%) 1572 (33·5%) 156 (3·8%) 33 620 (31·6%) NR NA
Unknown 1189 (18·2%) 28 (0·6%) 343 (8·4%) 14 451 (13·6%) NR NA
Ever used oral contraceptives
Yes 602 (7·8%) 2988 (55·1%) 791 (15%) 49 552 (42·8%) 15 047 (40·9%) NA
No 6649 (86·1%) 2286 (42·2%) 2110 (40%) 60 616 (52·4%) 20 289 (55·2%) NA
Unknown 471 (6·1%) 146 (2·7%) 2378 (45%) 5545 (4·8%) 1441 (3·9%) NA
Ever used HRT
Yes 571 (7·4%) 2391 (48·5%) 1244 (23·6%) 68 724 (59·4%) 16 886 (45·9%) NA
No 6571 (85·1%) 2626 (44·1%) 2517 (47·7%) 32 384 (28%) 18 434 (50·1%) NA
Unknown 580 (7·5%) 403 (7·4%) 1518 (28·7%) 14 605 (12·6%) 1457 (4%) NA
Menopausal status
Premenopausal 0 146 (2·7%) 304 (5·8%) 0 2942 (8%) NA
Perimenopausal 0 1134 (20·9%) 195 (3·7%) 0 0 NA
Postmenopausal 7722 (100%) 4013 (76·4%) 4780 (90·5%) 115 713 (100%) 33 316 (90·6%) NA
Unknown 0 0 0 0 519 (1·4%) NA
Data are mean (SD) or n (%), unless otherwise specified. EPIC=European Prospective Investigation into Cancer and Nutrition. ESTHER=Epidemiological Study on Chances of 
Prevention, Early Recognition and Optimised Treatment of Chronic Diseases in the Older Population. NHS=Nurses’ Health Study. SMC=Swedish Mammography Cohort. 
COSM=Cohort of Swedish Men. NR=not reported. BMI=body-mass index. NA=not applicable. HRT=hormone replacement therapy. *EPIC-Greece and EPIC-Umea are included. 
†The SMC and COSM studies did not provide information about BMI and alcohol. ‡Among parous women only.
Table 1: Study and participant characteristics at recruitment by cohort
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to YLD was 52% in men and 75% in women (table 3). 
The group aged 70–74 years had the largest absolute 
number of lost YLDs, whereas the group aged 80–84 years 
had the largest number of lost YLLs (table 3). The 
contribution of YLDs to the total number of DALYs was 
highest in the youngest age groups, ranging from over 
80% in participants aged 50–69 years to 44% in those 
older than 85 years (table 3).
The appendix shows the results of the sensitivity 
analyses after removal of the age-weighting and 
discounting functions, and adoption of different 
disability weights and excess mortality values. When the 
age-weighting and discounting functions were removed, 
the number of DALYs increased from 5964 to 11 145, and 
the YLD to YLL ratio decreased from 2·29 to 1·56 
(appendix p 3). When the excess mortality due to hip 
fracture was increased from 25% to 50%, the total 
number of DALYs increased to 6582 (appendix p 3). The 
most conservative approach for assignment of disability 
weights was that proposed by the initial GBD study,3 
which produced 2279 DALYs and increased to 
3860 DALYs when the results of a review made by 
Bertram and colleagues15 were included in the analysis 
(appendix p 4). When the disability weights from 
Netherlands burden of disease study were used,16 the 
calculated DALYs were 4344 (appendix p 4). The appendix 
presents these results in further detail by sex, age group, 
and cohort.
The appendix provides the HRs and 95% CIs for the 
association of the risk factors with hip fracture incidence 
and mortality by cohort, sex, and overall after pooling and 
meta-analysis of the data from the six participating 
cohorts. The HRs from the pooled analyses and the 
meta-analyses were in high agreement (appendix pp 18–
23). The results were similar when participants with 
missing information for any of the risk factors were 
excluded (data not shown). Table 4 depicts the population 
attributable fractions for risk factors that were statistically 
significant in the meta-analysis. Tobacco smoking was 
the risk factor responsible for the greatest hip fracture 
burden, followed by abstinence from vigorous physical 
activity (table 4). Diabetes and no use of HRT in women 
accounted for estimates of population attributable 
fractions of about 3% (95% CI 2–4) and 4% (2–6), 
respectively (table 4). Low BMI had a small effect, with 
estimates of population attributable fractions of 2% 
(95% CI 1–3) for a BMI of 18·5–21·5 kg/m² and 0·5% for 
a BMI lower than 18·5 kg/m² compared with a BMI of 
21·5–25 kg/m² (table 4). By contrast, a BMI larger than 
25 kg/m² had protective effects (table 4). Being overweight 
or obese was responsible for a reduction in DALYs that 
ranged from 7·2% (95% CI 4–11·2) for participants with 
a BMI of 25–30 kg/m², to 24·1% (14·4–32·9) for those 
with a BMI greater than 35 kg/m² (table 4). Low alcohol 
consumption (0·01–2·5 g/day) likewise led to a reduction 
in DALYs of 4·8% (95% CI 2·4–7·2; table 4). When we 
did the analysis separately by sex, alcohol consumption 
and BMI were no longer statistically significant in men, 
whereas in women the magnitude and direction of the 
risk estimates were similar to the overall population 
results (table 4). None of the remaining studied factors 
(ie, parity and oral contraceptive use) was significantly 
associated with hip fracture incidence or mortality.
Discussion
In this study of a large cohort consortium of middle-aged 
and older individuals in Europe and the USA followed up 
for 13 years, the burden of disease due to hip fracture was 
5964 DALYs or 27 DALYs per 1000 individuals, which 
translates to an average loss of 2·7% of the healthy life 
expectancy in this population. Disability predominated 
over mortality. Smoking, physical inactivity, and history 
of diabetes were the main risk factors responsible for the 
hip fracture burden, whereas high BMI and low alcohol 
consumption lessened the burden.
EPIC-Elderly* ESTHER Tromsø NHS SMC COSM
Total
Cases 318 (290) 104 (88) 554 (563) 2666 (167·2) 2549 (531·8) 1533 (287·9)
Deaths 5 (8·3) 1 (0·6) 0 97 (6) 145 (30·8) 165 (30·2)
Men
Cases 78 (138) 37 (62·5) 186 (473) NA NA 1533 (287·9)
Deaths 3 (10·4) 0 0 ·· ·· 165 (30·2)
Women
Cases 240 (423) 67 (107) 368 (616) 2666 (167·2) 2549 (513·5) NA
Deaths 2 (6·9) 1 (1) 0 97 (6) 145 (29·7) ··
Data in parentheses are age-standardised incidence per 100 000 person-years. EPIC=European Prospective Investigation 
into Cancer and Nutrition. ESTHER=Epidemiological Study on Chances of Prevention, Early Recognition and Optimised 
Treatment of Chronic Diseases in the Older Population. NHS=Nurses’ Health Study. SMC=Swedish Mammography 
Cohort. COSM=Cohort of Swedish Men. NA=not applicable. *EPIC-Greece and EPIC-Umea are included.
Table 2: Hip fracture incidence and mortality
Cases Deaths YLD YLL DALYs YLD:YLL YLD:DALYs
Total 7724 413 4150 1814 5964 2·29 0·7
Sex
Male 1834 168 758 704 1462 1·08 0·52
Female 5890 245 3392 1110 4502 3·06 0·75
Age group (years)
50–59 82 1 109 25 134 4·36 0·81
60–64 501 5 577 81 658 7·12 0·88
65–69 874 11 785 129 914 6·09 0·86
70–74 1264 30 886 263 1149 3·37 0·77
75–79 1664 70 839 391 1230 2·15 0·68
80–84 1853 136 636 525 1161 1·21 0·55
≥85 1486 160 318 400 718 0·8 0·44
Disability weights were 0·468 for the first year after the fracture, 0·17 for the second year, then discounted by 10% per year 
for subsequent years, as proposed by the National Osteoporosis Foundation.14 In the calculation of DALYs, we assumed 
that 25% of the deaths due to any cause within a year after the hip fracture were causally related. However, the table shows 
only the number of deaths directly linked to a hip fracture. YLD=years of life lost due to disability. YLL=years of life lost due 
to premature mortality. DALY=disability-adjusted life-year.
Table 3: DALYs for hip fracture
Articles
e244 www.thelancet.com/public-health   Vol 2   May 2017
These findings suggest that considerable opportunities 
exist for improvement of the health burden related to hip 
fractures in developed countries. National policies should 
be strengthened to reduce hip fracture incidence and 
mortality and to prevent disability. Our estimates differ 
from that calculated by Johnell and Kanis (6 DALYs per 
1000 individuals) for established market economies in 
their global burden of disease study,5 because we only 
included middle-aged and older adults and the estimation 
was based on incident cases. Thus, our results are not 
representative of the burden of disease due to prevalent 
and incident cases across all ages. Moreover, 
methodological differences in the calculation of DALYs 
exist between the studies.5,9 Unlike previous studies, we 
used real-life follow-up data of several cohorts that enable 
the prospective calculation of hip fracture incidence, 
mortality, risk factor, and confounding variables. For 
comparison, the burden of hip fractures in our study was 
smaller than that of 87 DALYs lost per 1000 individuals 
due to lung cancer, but was similar to the 33 DALYs and 
26 DALYs lost per 1000 individuals due to breast and 
pancreatic cancer, respectively, as reported in another 
study in the CHANCES consortium.18
Disability predominated over mortality in our study, 
which is in agreement with the global burden of disease 
study for established market economies.5 In view of the 
crisis in the treatment of osteoporosis, whereby patients 
are refusing effective treatments because of rare side-
effects or providers are refusing to prescribe them,19 the 
need to consider the effects of hip fracture interventions 
on reducing disability from the disease (ie, via a second 
hip fracture) should be emphasised. Furthermore, the 
effect of disability on the total burden weakened as 
participants aged, which was confirmed by the findings 
of another study.9 A plausible reason for this decline is 
that older individuals are more likely to die either from 
natural causes or due to a disease and therefore live fewer 
years with the disability. That the risk of death is higher 
for older individuals after a hip fracture is widely 
accepted.12,20 Therefore, primary prevention strategies 
should focus on the elderly population.
To our knowledge, this study is the first to calculate 
population attributable fractions for major risk factors 
causing loss of healthy life-years due to hip fracture. 
Smoking was the predominant risk factor, followed by 
abstaining from vigorous physical activity, no use of HRT 
in women, and type 2 diabetes. Although we cannot verify 
these attributable fractions by comparison with other 
studies because of the scarcity of published similar 
reports, the observed risk estimates were generally 
concordant in magnitude and direction with literature 
evidence from published meta-analyses.21–25 The 
calculation of attributable fractions was based on risk 
factor information collected at the baseline of each cohort 
and, although this approach has the advantage of 
measuring the risk factors at a period of causal relevance, 
it might not reflect present prevalence estimates of the 
risk factors.
Cohort studies and meta-analyses thereof have shown 
that low BMI increases the risk of hip fractures even 
after adjustment for bone mineral density.21,22 The exact 
mechanisms explaining this relationship are not clear, 
but a suggestion is that a low BMI, even within the 
normal limits of BMI classification, is associated with 
bone loss and hence a higher likelihood of a fracture.26 
A second hypothesis suggests that adipose tissue 
around the hip area can absorb part of the impact 
during the fall and protect against the fracture.27 In our 
analysis, the protective effect of high BMI was the 
largest among the different BMI categories; however, 
PAF (95% CI)
Overall
Smoking (current vs never) 7·5% (5·2 to 9·7)
Alcohol (no current use vs 0·01–2·5 g 
per day)
4·8% (2·4 to 7·2)
BMI (kg/m²)
<18·5 vs 21·5–25 0·56% (0·4 to 0·64)
18·5–21·5 vs 21·5–25 2·0% (1·4 to 2·7)
25–30 vs 21·5–25 –7·2% (–11·2 to –4·0)
30–35 vs 21·5–25 –13·6% (–19·2 to –7·2)
≥35 vs 21·5–25 –24·1% (–32·9 to –14·4)
Vigorous activity (no vs yes) 5·5% (2·1 to 8·5)
Diabetes (yes vs no) 2·8% (2·1 to 4·0)
Men
Smoking (current vs never) 7·0% (4·5 to 9·0)
Vigorous activity (no vs yes) 3·1% (2·0 to 4·4)
Diabetes (yes vs no) 3·0% (1·6 to 4·5)
Women
Smoking (current vs never) 6·5% (4·6 to 8·6)
Alcohol (no current use vs 0·01–2·5 g 
per day)
4·9% (2·4 to 7·3)
BMI (kg/m²)
<18·5 vs 21·5–25 0·57% (0·5 to 0·65)
18·5–21·5 vs 21·5–25 2·1% (1·4 to 2·9)
25–30 vs 21·5–25 –8·2% (–12·2 to –4·0)
30–35 vs 21·5–25 –14·7% (–20·4 to –7·3)
≥35 vs 21·5–25 –24·5% (–33·5 to –14·7)
Vigorous activity (no vs yes) 1·2% (0·8 to 1·6)
Diabetes (yes vs no) 2·1% (1·8 to 2·5)
Ever had HRT (no vs yes) 3·8% (1·7 to 5·8)
The risk factors were modelled with indicator variables, with the group of 
participants with the lowest expected population risk for hip fracture or death as 
the reference category. PAFs only for statistically significant risk factors are 
presented here. Negative values represent protective associations on the basis of 
the initial risk factor modelling, which were then reversed keeping the negative 
value to denote the change in the reference groups. The Swedish Mammography 
Cohort (SMC) and Cohort of Swedish Men (COSM) cohorts did not provide 
information about BMI and alcohol, and were therefore excluded from the 
relevant analyses. PAF=population attributable fraction. BMI=body-mass index. 
HRT=hormone replacement therapy.
Table 4: Proportion of total DALYs for hip fracture attributable to risk 
factors overall and by sex
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recommendation of an increase in the BMI over 
25 kg/m² is inappropriate because of the association 
with other morbidities.
Tobacco smoking is a well-known risk factor for hip 
fractures, acting mostly via the associated reduction in 
bone mineral density or through changes in circulating 
concentrations of oestradiol, parathyroid hormone, and 
vitamin D that consequently affect calcium absorption 
and proliferation of bone cells.26 The results of the 
present study were in agreement with a pooled analysis 
of ten prospective cohorts, which estimated that current 
smoking yielded a 65% higher risk of hip fracture than 
never smoking (risk ratio 1·65, 95% CI 1·34–2·03).23 
Furthermore, we confirmed that vigorous physical 
activity, use of HRT, and absence of type 2 diabetes were 
inversely associated with risk of hip fractures.24,28,29
Abstinence from alcohol was positively associated with 
the risk of hip fracture compared with low alcohol 
consumption (in this study defined as 0·01–2·5 g/day). 
Unfortunately, we could not evaluate the effect of heavy 
alcohol consumption because only a small proportion of 
our study population belonged to that category. Our results 
were in partial agreement with a 2014 meta-analysis in 
which low alcohol consumption (0·01–12·5 g/day) was 
associated with a lower risk of hip fracture than no 
consumption (relative risk 0·88, 95% CI 0·83–0·89) and 
high consumption (≥50 g/day) was associated with a 
higher risk (1·71, 1·41–2·01).25 Low alcohol consumption 
has been generally associated with increased bone mineral 
density, whereas heavy consumption has an adverse effect 
on bone health.30
Our study has some limitations. The calculation of 
DALYs depends on several assumptions, and our findings 
should therefore be interpreted with caution. We used 
disability weights for hip fractures proposed by the 
National Osteoporosis Foundation,13 because they are 
suitable for countries within the established market 
economies, such as those participating in our study. We 
did not use the disability weights proposed by WHO in 
our main analysis, because they have been suggested to 
underestimate the short-term and long-term effect of hip 
fractures,15 which was shown further in our sensitivity 
analyses. Moreover, our study included healthy volunteers 
participating in well-established prospective cohorts, 
who might not be representative of patients with hip 
fracture in the general population.
Few data are available for mortality due to hip fracture 
worldwide. Although hip fracture is not commonly 
directly noted as a cause of death, many studies have 
reported that elderly individuals in particular have an 
increased risk of death after a hip fracture.31,32 Therefore, 
in order not to underestimate the true effect of hip 
fracture, we considered that 25% of the excess mortality 
after the hip fracture is causally related to the fracture 
itself.12 This assumption was derived from a Swedish 
population and it might be logical to assume that in our 
study the excess mortality is similar. As expected, 
changing assumptions concerning the excess mortality 
(eg, 0, 25%, 50%, 100%) after hip fracture had an effect on 
DALYs. Interpretation of our main results should be 
conservative to avoid overestimation of the effect of the 
DALYs. In general, the calculation of DALYs in the present 
study was sensitive to the underlying assumptions, but 
such changes were expected and have been observed in 
previous global burden of disease studies.5,9
With these reservations, our study suggests that hip 
fractures are an important cause primarily of disability, 
but also mortality among middle-aged and older adults. 
Considerable opportunities exist to ameliorate the 
burden of hip fractures via a focus on treatments that 
will facilitate a rapid and complete recovery. Primary 
prevention measures should be also strengthened to 
prevent falls, and individuals should be encouraged to 
avoid smoking and a sedentary lifestyle.
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